FLAMMINI, Lisa
 Distribuzione geografica
Continente #
NA - Nord America 2.166
EU - Europa 1.968
AS - Asia 1.033
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
SA - Sud America 1
Totale 5.218
Nazione #
US - Stati Uniti d'America 2.127
CN - Cina 594
IT - Italia 400
FI - Finlandia 395
IE - Irlanda 380
SE - Svezia 349
SG - Singapore 290
DE - Germania 147
UA - Ucraina 110
TR - Turchia 80
IN - India 42
CI - Costa d'Avorio 38
NL - Olanda 37
CA - Canada 36
FR - Francia 35
GB - Regno Unito 33
BE - Belgio 26
CZ - Repubblica Ceca 15
RO - Romania 9
PL - Polonia 6
AT - Austria 5
CH - Svizzera 5
EU - Europa 5
KR - Corea 5
JP - Giappone 4
VN - Vietnam 4
ES - Italia 3
PA - Panama 3
RU - Federazione Russa 3
IR - Iran 2
LT - Lituania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SC - Seychelles 2
TH - Thailandia 2
TW - Taiwan 2
AZ - Azerbaigian 1
CM - Camerun 1
DZ - Algeria 1
HK - Hong Kong 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
NG - Nigeria 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
UY - Uruguay 1
Totale 5.218
Città #
Chandler 398
Dublin 379
Singapore 234
Santa Clara 227
Ann Arbor 222
Parma 167
Dearborn 149
Jacksonville 144
Beijing 125
Ashburn 118
Boardman 101
Shanghai 80
Nanjing 76
Izmir 73
Princeton 60
New York 52
Wilmington 39
Abidjan 38
Bremen 35
Groningen 33
Milan 30
San Mateo 29
Bangalore 27
Helsinki 27
Brussels 25
Kunming 25
Toronto 25
Chicago 24
Des Moines 23
Hebei 22
Jinan 22
Guangzhou 20
Shenyang 20
Nanchang 19
Marseille 18
Changsha 17
Fremont 16
Hefei 16
Seattle 16
Los Angeles 15
Munich 15
Norwalk 13
Redmond 13
Brno 12
Jiaxing 12
Houston 11
Tianjin 11
Montegaldella 9
Grafing 8
Modena 8
Woodbridge 8
Dallas 7
Ottawa 7
Redwood City 7
Reggio Emilia 7
Hangzhou 6
Pune 6
Zhengzhou 6
Bologna 5
Kraków 5
Lanzhou 5
London 5
Taizhou 5
West Jordan 5
Altidona 4
Ardea 4
Carpi 4
Chengdu 4
Düsseldorf 4
Falls Church 4
Haikou 4
Kocaeli 4
Palermo 4
Pesaro 4
Rome 4
Baotou 3
Brescia 3
Finale Emilia 3
Frankfurt am Main 3
Fuzhou 3
Manchester 3
Mantova 3
Mestre 3
Ningbo 3
Phoenix 3
Stockholm 3
Timisoara 3
Tulsa 3
Vienna 3
Zurich 3
Assago 2
Bangkok 2
Bergamo 2
Brooklyn 2
Chiari 2
Collecchio 2
Dong Ket 2
Duncan 2
Fairfield 2
Florence 2
Totale 3.491
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 198
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 167
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 150
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 133
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 124
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 117
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 117
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 112
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 110
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 106
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 106
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 106
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 105
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 98
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 97
Hake fish bone as a calcium source for efficient bone mineralization 93
Antitumoral effect of a nanotechnology-based photodynamic therapy. 91
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 90
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 90
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 89
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 88
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 87
Analgesic activity of new hybrid muscarinic agonists in mice 87
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 86
Rifaximin anti-inflammatory activity on bovine endometrium primary cell cultures: a preliminary study 86
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 83
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 83
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 80
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 80
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 79
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 78
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 78
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 78
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 76
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 73
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 72
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 72
Brain Pharmacokinetics of Non-Imidazole Biphenyl H3 Receptor Antagonists: a Liquid Chromatography/Electrospray-Mass Spectrometry and ex vivo Binding Study in Rats 71
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 70
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 70
Lithocholic acid competitively inhibits EphA2-ephrinA1 binding: pharmacological and structural considerations. 69
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 69
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 69
Lithocholic acid competitively inhibitis EphA2-ephrinA1 binding: pharmacological and structural considerations. 68
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation. 68
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 67
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 67
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 67
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 65
Aminopyridine derivatives with anticholinesterase and antiamnesic activity 65
α7 Nicotinic Agonist AR-R17779 Protects Mice against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in a Spleen-Dependent Way 64
EphA2-ephrinA1 system in acute mesenteric inflammation due to ischemia-reperfusion in mice 61
In vitro pharmacology at human histamine H(3) receptors and brain access of non-imidazole alkylpiperidine derivatives. 60
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines 58
Analgesic effects mediated by muscarinic ligands acting at both orthosteric and allosteric receptor binding sites 57
Novel potent N-Methyl-d-Aspartate (NMDA) receptor antagonists or s1 receptor ligands based on properly substituted 1,4-dioxane ring 57
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 57
Synthesis and characterization of new bivalent agents as melatonin- and histamine h3-ligands. 53
New selective PDE4D inhibitors devoid of sedative effects in mice 49
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 48
Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors 45
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 44
Su1816–Protection by Ccr6 Blockade in a Murine Model of Crohn’s Disease 37
Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2 34
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice 31
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 12
Totale 5.317
Categoria #
all - tutte 19.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020368 0 0 0 0 0 0 119 21 63 94 28 43
2020/2021444 7 43 22 23 73 37 56 19 68 21 56 19
2021/2022391 21 16 25 48 24 17 32 32 18 27 13 118
2022/20231.393 168 170 84 106 129 154 30 63 407 14 53 15
2023/2024656 23 54 12 29 43 143 67 36 24 37 70 118
2024/2025793 84 87 114 124 188 196 0 0 0 0 0 0
Totale 5.317